Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-100 in Patello-Femoral Osteoarthritis
NCT01925261Phase 2Completed
- Sponsor
- OrthoTrophix, Inc.
- Start
- Jan 2014
- Primary completion
- Sep 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TPX-100 in osteoarthritis (OA), sponsored by OrthoTrophix, Inc.. Started Jan 2014; status: completed.
02
Drugs
TPX-100
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01925261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925261.